Split History
ETFs Holding TERN »    TERN Historical Stock Prices »

Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates to address diseases, such as non-alcoholic steatohepatitis (NASH) and obesity. Co.'s primary program is TERN-101, a liver-distributed, non-bile acid Farnesoid X Receptor (FXR) agonist that has demonstrated sustained liver FXR activation, as well as a favorable tolerability profile across multiple clinical trials. Co.'s another clinical stage program, TERN-201, is an inhibitor of Vascular Adhesion Protein-1. Co. is also evaluating the potential to co-administer TERN-201 in combination with a metabolically active NASH treatment. According to our TERN split history records, Terns Pharmaceuticals has had 1 split.
TERN split history picture
Terns Pharmaceuticals (TERN) has 1 split in our TERN split history database. The split for TERN took place on May 08, 2000. This was a 2 for 1 split, meaning for each share of TERN owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split.

When a company such as Terns Pharmaceuticals splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.

Looking at the TERN split history from start to finish, an original position size of 1000 shares would have turned into 2000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Terns Pharmaceuticals shares, starting with a $10,000 purchase of TERN, presented on a split-history-adjusted basis factoring in the complete TERN split history. TERN split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 02/08/2021
End date: 04/17/2024
Start price/share: $19.79
End price/share: $4.54
Dividends collected/share: $0.00
Total return: -77.06%
Average Annual Total Return: -37.00%
Starting investment: $10,000.00
Ending investment: $2,294.24
Years: 3.19
Date Ratio
05/08/20002 for 1
TERN is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

TEVA Split History
TFFP Split History
TFX Split History
TGTX Split History
TGX Split History
THAR Split History
THC Split History
THMO Split History
THRD Split History
THRX Split History

Also explore: TERN shares outstanding history

Email EnvelopeFree TERN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Golden Sun Health Technology Group Limited (GSUN)
Zapp Electric Vehicles Group Limited (ZAPP)
Beneficient (BENF)
MySize, Inc. (MYSZ)
Gorilla Technology Group Inc. (GRRR)
Sunshine Biopharma, Inc. (SBFM)
NFT Ltd. (MI)
WiSA Technologies, Inc. (WISA)
Fluent, Inc. (FLNT)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

TERN Insider Buying

TERN Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.